tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT

Editas Medicine (EDIT) Revenue

Compare
3,558 Followers

Editas Medicine Revenue

Editas Medicine had a revenue of 24.74M in the quarter ending Dec 31, 2025, with 228.00%. This bring the company's revenue in the last twelve months to 40.52M, Increased -12.64%. In the fiscal year ending Dec 31, 2025, Editas Medicine had annual revenue of 40.52M with 25.39% growth.
Revenue (ttm)
40.52M
Revenue Growth
-24.90%
P/S Ratio
5.80
Revenue/Employee
$164,715
Employees
246
Market Cap
$234.89M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
40.52M8.21M+25.39%
Dec 31, 2024
32.31M-45.81M-58.64%
Dec 31, 2023
78.12M58.41M+296.32%
Dec 31, 2022
19.71M-5.83M-22.83%
Dec 31, 2021
25.54M-65.19M-71.85%
Dec 31, 2020
90.73M70.20M+341.93%
Dec 31, 2019
20.53M-11.41M-35.71%
Dec 31, 2018
31.94M18.21M+132.64%
Dec 31, 2017
13.73M